Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
d

d1000 Varejo Farma Participacoes SA
BOVESPA:DMVF3

Watchlist Manager
d1000 Varejo Farma Participacoes SA
BOVESPA:DMVF3
Watchlist
Price: 6.76 BRL -0.59%
Market Cap: R$342.1m
Write Note Create Alert Ask AI

Relative Value

The Relative Value of one DMVF3 stock under the Base Case scenario is 14.19 BRL. Compared to the current market price of 6.76 BRL, d1000 Varejo Farma Participacoes SA is Undervalued by 52%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DMVF3 Relative Value
Base Case
14.19 BRL
Undervaluation 52%
Relative Value
Price
d
Worst Case
Base Case
Best Case

Valuation Multiples

P/S
View Details
P/E
View Details
P/OCF
View Details
P/FCFE
View Details
P/B
View Details
EV/S
View Details
EV/GP
View Details
EV/EBITDA
View Details
EV/EBIT
View Details
EV/OCF
View Details
EV/FCFF
View Details
EV/IC
View Details

Multiples Across Competitors

DMVF3 Competitors Multiples
d1000 Varejo Farma Participacoes SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
BR
d1000 Varejo Farma Participacoes SA
BOVESPA:DMVF3
344.1m BRL 0.1 20.7 3.3 9.5
ZA
Clicks Group Ltd
JSE:CLS
77.8B ZAR 1.7 25.9 12.7 17.9
ZA
Dis-Chem Pharmacies Ltd
JSE:DCP
31B ZAR 0.8 26.2 10.6 16
US
Walgreens Boots Alliance Inc
NASDAQ:WBA
10.4B USD 0.1 -1.6 3 5.1
BR
Raia Drogasil SA
BOVESPA:RADL3
45.1B BRL 1.1 35.8 11.6 21.2
JP
Tsuruha Holdings Inc
TSE:3391
1.1T JPY 1 31.8 13.9 20.6
JP
MatsukiyoCocokara & Co
TSE:3088
1T JPY 0.9 17.9 8.3 10.6
SA
Al Nahdi Medical Company SCJSC
SAU:4164
16.8B SAR 1.7 20.7 10.4 19.2
JP
Welcia Holdings Co Ltd
TSE:3141
657.7B JPY 0.5 34.3 9.1 15.3
CN
Yifeng Pharmacy Chain Co Ltd
SSE:603939
28.6B CNY 1.2 17.4 13.6 13.6
JP
Sugi Holdings Co Ltd
TSE:7649
639B JPY 0.6 15.1 9.2 13

See Also

Summary
DMVF3 intrinsic value, competitors valuation, and company profile.
DCF Valuation
DMVF3 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DMVF3 stock valuation using valuation multiples.
Wall Street Estimates
DMVF3 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DMVF3 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 314,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.